Modafinil: A gift to portmanteau

American Journal of Hospice and Palliative Medicine

Volumn 18, Issue 6, 2001, Pages 408-410

  Cox, Joshua M ^a   Pappagallo, Marco ^b  

^a Ohio Pain Initiative   (United States)

^b University School of Medicine   (United States)

Author keywords

a1 antagonists; antidepressants; depression; fatigue; modafinil; palliative care; pharmacokinetics; pharmacotherapy; psychopharmacology; psychostimulants; symptom management; vigilance; wakefulness

Indexed keywords

BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT; MODAFINIL;

DEPRESSION; DRUG EFFECT; DRUG INTERACTION; DRUG MONITORING; FATIGUE; HUMAN; METHODOLOGY; PATIENT SELECTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SLEEP STAGE; TERMINAL CARE;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; DRUG INTERACTIONS; DRUG MONITORING; FATIGUE; HUMANS; PATIENT SELECTION; QUALITY OF LIFE; SLEEP STAGES; TERMINAL CARE;

EID: 0035514163     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990910101800611     Document Type: Article

References (13)

1. McClellan KJ, Spencer CM: Modafinil: A review of its pharmacology and clinical efficacy in the management of narcolepsy. CNS Drugs. 1998; 9: 311-324.
2. US Modafinil in Narcolepsy Multicenter Study Group: Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 2000; 54: 1166-1175.
3. Wisor JP, Nishino S, Sora I, et al.: Dopaminergic role in stimulant-induced wakefulness. J Neuroscience. 2001; 21(5): 1787-1794.
4. Lin JS, Hou Y, Jouvet M: Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc National Academy of Science (USA). 1996; 93: 14128-14133.
5. Wong YN, King SP, Simcoe D, et al.: Open-label, single-dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects. J Clinical Pharmacology. 1999; 39(3): 281-288.
6. Wong YN, Simcoe D, Hartman LN, et al.: A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers. J Clinical Pharmacology. 1999; 39(1): 30-40.
7. Cochran JW: Effect of modafinil on fatigue associated with neurological illnesses. J Chronic Fatigue Syndrome. 2001; 8(2): 65-70.
8. Menza MA, Kaufman KR, Castellanos A: Modafinil augmentation of antidepressant treatment in depression. J Clinical Psychiatry. 2000; 61: 378-381.
9. Portenoy RK, Itri LA: Cancer-related fatigue: Guidelines for evaluation and management. The Oncologist. 1999; 4: 1-10.
10. Kim HF, Braun U, Kunik ME: Anxiety and depression in medically ill older adults. J Clinical Geropsychology. 2001; 7(2): 117-130.
11. Twycross R: Symptom Management in Advanced Cancer. Oxford, Radcliffe Medical Press, 1997.
12. McKevoy KG (ed.): American Hospital Formulary Service Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 2001.
13. Davis MP, Dickerson ED, Pappagallo M, et al.: Mirtazapine: Heir apparent to amitriptyline? American J Hospice & Palliative Care. 2001; 18(1): 42-46.